Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
2000
Using PET Scans to Detect Testicular Cancer Recurrence
Sample size: 55
publication
Evidence: high
Author Information
Author(s): Hain S F, O’Doherty M J, Timothy A R, Leslie M D, Harper P G, Huddart R A
Primary Institution: The Clinical PET Centre, Department of Clinical Oncology, Guy’s and St Thomas’ Hospitals, London
Hypothesis
Can FDG-PET effectively differentiate between active disease and fibrosis/mature teratoma in testicular cancer patients?
Conclusion
FDG-PET is effective in detecting viable tumors and can influence management decisions in testicular cancer patients.
Supporting Evidence
- FDG-PET had a positive predictive value of 96% in patients with residual masses.
- The negative predictive value of FDG-PET was 90% in the same group.
- FDG-PET scanning detected viable tumor in residual masses.
- FDG-PET identified sites of disease in suspected recurrence.
- Management changed in 57% of cases based on FDG-PET results.
Takeaway
Doctors used special scans to find out if testicular cancer was coming back, and they found it worked really well in most cases.
Methodology
Retrospective study analyzing FDG-PET scans in patients with residual masses or raised markers after treatment.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website